Everolimus
FDA Approved: * June 8, 2020Pharm Company: * WEST-WARD PHARMS INT
Category: Cancer
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Everolimus Overview
Everolimus is a medication used as an immunosuppressant to prevent rejection of organ transplants and in the treatment of renal cell cancer and other tumours.[medical citation needed] Much research has also been conducted on everolimus and other mTOR inhibitors as targeted therapy for use in a number of cancers.[medical citation needed] It is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an inhibitor of mammalian target o...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Everolimus
Recent Everolimus Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Everolimus
- Suspension: 2mg, 3mg, 5mg
- Tablet: 0.25mg, 0.5mg, 0.75mg, 10mg, 1mg, 2.5mg, 5mg, 7.5mg
- Tablet, For Suspension: 2mg, 3mg, 5mg
NDC Database Records for Everolimus: (15 results)
Sorted by National Drug Code- 0054-0470 Everolimus .25 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
- 0054-0471 Everolimus .5 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
- 0054-0472 Everolimus .75 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
- 0054-0480 Everolimus 2.5 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
- 0054-0481 Everolimus 5 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
- 0054-0497 Everolimus 7.5 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
- 0093-7766 Everolimus 2.5 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
- 0093-7767 Everolimus 5 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
- 0093-7768 Everolimus 7.5 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
- 0378-3096 Everolimus 2.5 mg Oral Tablet by Mylan Pharmaceuticals Inc.
- 0378-3097 Everolimus 5 mg Oral Tablet by Mylan Pharmaceuticals Inc.
- 0378-3098 Everolimus 7.5 mg Oral Tablet by Mylan Pharmaceuticals Inc.
- 49884-119 Everolimus 2.5 mg Oral Tablet by Par Pharmaceutical, Inc.
- 49884-125 Everolimus 5 mg Oral Tablet by Par Pharmaceutical, Inc.
- 49884-127 Everolimus 7.5 mg Oral Tablet by Par Pharmaceutical, Inc.
Other drugs which contain Everolimus or a similar ingredient: (4 results)
- AFINITOR Everolimus3 discussions
- AFINITOR DISPERZ Everolimus
- CERTICAN Everolimus
- ZORTRESS Everolimus
Related Everolimus Topics:
Everolimus Face Rash
Side Effects of Everolimus including face and body rash; swollen feet...
Side Effects of Everolimus including face and body rash; swollen feet...
Everolimus Side Effects
Everolimus Side Effects: Face and Body Rash...
Everolimus Side Effects: Face and Body Rash...